Control of oncogenesis and cancer therapy resistance. - Wikidata - wikimedia - TriplyDB

Control of oncogenesis and cancer therapy resistance.

Control of oncogenesis and cancer therapy resistance.

http://www.wikidata.org/entity/Q35647850

about

Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance Reversibility of apoptosis in cancer cells.Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.Targeted therapies in breast cancer.Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.Hematopoietic stem cells: the paradigmatic tissue-specific stem cell.Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patients PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance.14-3-3 eta depletion sensitizes glioblastoma cells to irradiation due to enhanced mitotic cell death.Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy.Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts.The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1.

P2860

Q26778761-B6E78499-0AF2-426A-A603-2692CDB61959 Q30485754-46D958B7-E233-4F44-9EFA-7203F499A6FE Q34793171-AC2A10E9-FB6F-4F5B-B7C3-55166784E7A6 Q36051459-BAB500B3-D90E-456D-8E93-8EF6B19E3015 Q36386755-8FF58910-0DEE-44C7-A35D-32B7DD27F0FB Q36551160-22BB266B-F143-48E5-8FC1-FD3D642EA2A0 Q37244377-D6112F12-EFCB-4B39-91DB-078C5149CD82 Q38867874-BDB1C8DE-63B1-4B01-AF44-04D7FD2732D3 Q39015881-B9029DD6-890F-45D7-B314-8E8060998590 Q39556387-44FAF924-7A98-47B1-BA6C-58FD778763A6 Q40020098-9F358A94-C752-47C0-A288-C9F8190CBDE8 Q40518217-385DB40E-9CFA-4AFC-B421-1D6F896FD7DD

P2860

Control of oncogenesis and cancer therapy resistance.

http://www.wikidata.org/entity/Q35647850

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Control of oncogenesis and cancer therapy resistance.

@ast

Control of oncogenesis and cancer therapy resistance.

@en

type

label

Control of oncogenesis and cancer therapy resistance.

@ast

Control of oncogenesis and cancer therapy resistance.

@en

prefLabel

Control of oncogenesis and cancer therapy resistance.

@ast

Control of oncogenesis and cancer therapy resistance.

@en

P1433

Q35647850-F6135538-BAC3-429A-8F80-7B651F851B85

P1476

Q35647850-D246DDED-5E3C-4F88-B097-3B25CE4C194A

P2093

Q35647850-2AB96412-C136-4FFA-8BC9-D91FD325A651

Q35647850-944872B8-692E-4039-8DC9-DFA6A04A132C

P2860

Q35647850-04484CA0-5F6F-404D-A5EC-22F57C30ED24

Q35647850-075EB19F-C193-4F16-9C24-578171F480E7

Q35647850-1C392EC3-E646-44A2-BF51-89A41B7DBE6D

Q35647850-26E293A1-C327-4CE3-9CE2-A6155FDD8186

Q35647850-2EA4EA2F-939E-470E-B0C5-5F9EF2583C8B

Q35647850-326917AB-28C0-49CB-A617-350C37A83623

Q35647850-40F27D9F-8F79-41B3-999A-8D26BBBBB05C

Q35647850-5095A05A-8C0B-4659-BF26-6C29D7C87F23

Q35647850-58A69D1E-0B0E-40D9-8FD3-C9B132EFE1EB

Q35647850-59331EA6-AADF-4497-AE69-C507AF5BCF5C

P2888

Q35647850-9400E7FD-4413-41E0-A117-B059A99C2F63

P304

Q35647850-2B2E2DDA-F18C-4245-8AD2-362CF052ACD9

P31

Q35647850-6D75D6A9-A1E5-44A8-895A-4D70CD1239D3

Q35647850-F567F85D-ECDE-4897-96FE-959A6E34CEF6

P356

Q35647850-88B72BE4-C0A0-496B-B737-464DD431AF7C

P407

Q35647850-0B3B1F54-0FF3-46D6-9BBD-824DE30697B5

P433

Q35647850-018DD5F3-7F7C-4B69-8FFA-F720DC560E47

P478

Q35647850-A1265ADF-F4FA-4B9E-A443-35B6776E9FDD

P577

Q35647850-4F42F126-9696-496E-87F2-6A14B38B7A26

Q35647850-53E99449-14C8-4A91-AC02-28C68B3E6291

P5875

Q35647850-ABD5087F-5390-4B71-B98D-2007FBB020AB

P6179

Q35647850-0904F2A3-7F94-4F7D-AA55-CFA111D118F3

P698

Q35647850-6C73AFFE-A8BF-4E8C-AB34-D488DAD6177D

P921

Q35647850-7FC339F1-EB09-494E-A615-0B70CC1F483E

Q35647850-9DA61C95-F992-4E72-B798-29E2EC7E3504

P932

Q35647850-85D770BA-D2F9-49B3-A51E-F16C2234D045

P356

P1433

British Journal of Cancer

P1476

Control of oncogenesis and cancer therapy resistance.

@en

P2093

I Sánchez-Pérez

http://www.w3.org/2001/XMLSchema#string

R Perona

http://www.w3.org/2001/XMLSchema#string

P2860

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Targeting RAS signalling pathways in cancer therapy

Akt1 regulates a JNK scaffold during excitotoxic apoptosis

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

NF-kappaB in cancer: from innocent bystander to major culprit

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.

Mechanisms of p53-dependent apoptosis.

P2888

P304

573-577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601552

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2004-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8889044

http://www.w3.org/2001/XMLSchema#string

P6179

1041974888

http://www.w3.org/2001/XMLSchema#string

P698

14760366

http://www.w3.org/2001/XMLSchema#string

P921

physiological phenomena

P932

2409594

http://www.w3.org/2001/XMLSchema#string